Open AccessIvermectin mass drug administration for onchocerciasis elimination: can it reduce the prevalence of scabies in Ethiopia?
Author(s) -
Tsigereda Amsalu,
Wendemagegn Enbiale,
Neguse Manaye,
Ashenafi Ayalew,
Addisu Workineh,
Henry De Vries,
Johan van Griensven
Publication year - 2022
Publication title -
journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.15975
Subject(s) - ivermectin , onchocerciasis , scabies , mass drug administration , onchocerca volvulus , medicine , filariasis , drug , antiparasitic agent , administration (probate law) , drug administration , dermatology , veterinary medicine , environmental health , immunology , pharmacology , helminths , population , political science , law
While ivermectin mass drug administration (MDA) has been implemented since long for onchocerciasis elimination, there is doubt whether this would also be effective for scabies control. If effective, this would allow integration of both programs. We compared scabies prevalence in districts implementing ivermectin MDA for the onchocerciasis elimination program and those not implementing the intervention in Amhara region, Ethiopia.